<?xml version="1.0" encoding="UTF-8"?>
<p>Following the observation that 
 <italic>Pichia</italic>-derived VLPs showed characteristics similar to those of ECs, we next determined their antigenic character by enzyme-linked immunosorbent assay (ELISA). We analyzed gradient fractions using a standard protocol, as established by the National Institute for Biological Standards and Control (NIBSC), using the current inactivated vaccine (BRP) as a positive control (
 <xref rid="B36" ref-type="bibr">36</xref>).
</p>
